Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination therapy in patients (pts) with advanced melanoma (MEL) Meeting Abstract
| Authors: | Sznol, M.; Ferrucci, P. F.; Hogg, D.; Atkins, M.; Wolter, P.; Guidoboni, M.; Lebbe, C.; Kirkwood, J.; Schachter, J.; Daniels, G.; Hassel, J.; Cebon, J.; Gerritsen, W.; Atkinson, V.; Thomas, L.; McCaffrey, J.; Power, D.; Jiang, J.; Hodi, F. S.; Wolchok, J. |
| Abstract Title: | Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination therapy in patients (pts) with advanced melanoma (MEL) |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi385 |
| Language: | English |
| ACCESSION: | WOS:000393913000216 |
| DOI: | 10.1093/annonc/mdw379.18 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1123P -- Source: Wos |
